Edgen Stock·Sep 08 2025, 08:12戻る
戻る
Gilead Sciences Expands Global HIV Prevention Access Through Strategic Partnerships
Edgen Stock·Sep 08 2025, 08:12
[1] Gilead Sciences advances HIV prevention with US partnership[2] Gilead Finalizes Agreement With the Global Fund to Accelerate Access to Twice Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low and Lower Middle Income Countries[3] Gilead Announces Partnership With PEPFAR to Deliver Twice Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low and Lower Middle Income Countries